Expanding evidence in heart failure patients: the COMMANDER HF trial.
Alterations in clot architecture associated with low fibrinolytic potential in acute myocardial infarction
What are the clinical implications for management of heart failure patients with diabetes?
Hybrid ablation - A role in atrial fibrillation management?
New paradigms in vascular protection: exploring heart failure and Coronary Artery Disease.
Design and rationale of the EMPagliflozin outcome trial in patients with chronic heart failure (EMPEROR-Reduced)
COMMANDER HF - Randomized Study Comparing Rivaroxaban with Placebo in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Closing remarks - New directions in the management of thrombotic risks in patients with heart failure.